Analysts Viewpoint Goldman gives a Sell recommendation for Nautilus Biotechnology Inc (NAUT) Nautilus Biotechnology Inc’s recent filing unveils that its CEO, President, and Secretary Patel Sujal M acquired Company’s shares for reported
Stock Earnings NAUT price target predicted to rise nearly 2.5 in 12 months Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Nautilus Biotechnology
Insiders Updates NAUT short interest fall by -7.36%, reflecting positive sentiment Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Nautilus Biotechnology
Analysts Viewpoint Nautilus Biotechnology Inc’s latest rating changes from various analysts Nautilus Biotechnology Inc’s recently made public that its CFO and Treasurer Mowry Anna acquired Company’s shares for reported $11488.0 on